MMP9 and cancer: In addition, the confirmation that MMP9 is involved in triggering the angiogenic switch came from a multistage pancreatic carcinogenesis model of transgenic RIP1-Tag2 mice in which both MMP2 and MMP9 were found to be up-regulated, rendering good correlation with the metastatic ability of a wide range of cancer cells [23].